Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical TrialsRoy F Chemaly, Sunwen Chou, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell TransplantationFrancisco M Marty, Drew J Winston, Roy F Chemaly, et al.
Infection Control and Hospital Epidemiology|September 27, 2017
The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention BehaviorsFrances M Weaver, William E Trick, Charlesnika T Evans, et al.
The Journal of Infectious Diseases|August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adultsKathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell TransplantationKathleen M Mullane, Drew J Winston, Ajay Nooka, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Pageof 5